SUNRISE, Fla., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company developing core technologies aimed at serving the heart failure patient population, announced today that eight of its affiliated researchers will present data at the upcoming Fifth International Conference on Cell Therapy for Cardiovascular Disease, January 14-16, 2009, at The New York Academy of Medicine, 1216 Fifth Avenue at East 103rd Street, New York, New York.
